Sortilin-related VPS10 domain containing receptor 1 and Alzheimer's disease-associated allelic variations preferentially exist in female or type 2 diabetes mellitus patients in southern Han Chinese

Psychogeriatrics

Volumn 12, Issue 4, 2012, Pages 215-225

  He, Yanqin ^a   Fang, Zhuyuan ^a   Yu, Guran ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Alzheimer's disease; Polymorphism; SORCS1

Indexed keywords

APOLIPOPROTEIN; SORTILIN; SORTILIN RELATED VPS10 DOMAIN CONTAINING RECEPTOR 1; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84871839229     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2012.00405.x     Document Type: Article

References (35)

1. Bertram L, Tanzi RE. Alzheimer's disease: one disorder, too many genes? Hum Mol Genet 2004; 13 (Spec No 1): R135-R141.
2. Nyborg AC, Ladd TB, Zwizinski CW, Lah JJ, Golde TE. Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates. Mol Neurodegener 2006; 1: 3.
3. Reitz C, Tokuhiro S, Clark LN etal. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol 2011; 69: 47-64.
4. Grupe A, Li Y, Rowland C etal. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet 2006; 78: 78-88.
5. Li H, Wetten S, Li L etal. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 2008; 65: 45-53.
6. Liang X, Slifer M, Martin ER etal. Genomic convergence to identify candidate genes for Alzheimer disease on chromosome 10. Hum Mutat 2009; 30: 463-471.
7. Laumet G, Chouraki V, Grenier-Boley B etal. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study. J Alzheimers Dis 2010; 20: 1181-1188.
8. Reiman EM, Webster JA, Myers AJ etal. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007; 54: 713-720.
9. Schjeide BM, McQueen MB, Mullin K etal. Assessment of Alzheimer's disease case-control associations using family-based methods. Neurogenetics 2009; 10: 19-25.
10. Clee SM, Yandell BS, Schueler KM etal. Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet 2006; 38: 688-693.
11. Granhall C, Park HB, Fakhrai-Rad H, Luthman H. High-resolution quantitative trait locus analysis reveals multiple diabetes susceptibility loci mapped to intervals <800kb in the species-conserved Niddm1i of the GK rat. Genetics 2006; 174: 1565-1572.
12. Goodarzi MO, Lehman DM, Taylor KD etal. SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes 2007; 56: 1922-1929.
13. Luo Y, Tang S, Gao W etal. Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions. Clin Chem Lab Med 2010; 48: 475-483.
14. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-98.
15. Li Z, Zhang Z, He Z etal. A partition-ligation-combination-subdivision EM algorith for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009; 19: 519-523.
16. Hermans-Borgmeyer I, Hampe W, Schinke B etal. Unique expression pattern of a novel mosaic receptor in the developing cerebral cortex. Mech Dev 1998; 70: 65-76.
17. Hermans-Borgmeyer I, Hermey G, Nykjaer A, Schaller C. Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development. Brain Res Mol Brain Res 1999; 65: 216-219.
18. Hermey G, Riedel IB, Rezgaoui M, Westergaard UB, Schaller C, Hermans-Borgmeyer I. SorCS1, a member of the novel sorting receptor family, is localized in somata and dendrites of neurons throughout the murine brain. Neurosci Lett 2001; 313: 83-87.
19. Rezgaoui M, Hermey G, Riedel IB, Hampe W, Schaller HC, Hermans-Borgmeyer I. Identification of SorCS2, a novel member of the VPS10 domain containing receptor family, prominently expressed in the developing mouse brain. Mech Dev 2001; 100: 335-338.
20. Hermey G, Keat SJ, Madsen P, Jacobsen C, Petersen CM, Gliemann J. Characterization of sorCS1, an alternatively spliced receptor with completely different cytoplasmic domains that mediate different trafficking in cells. J Biol Chem 2003; 278: 7390-7396.
21. Payao SL, Smith MD, Bertolucci PH. Differential chromosome sensitivity to 5-azacytidine in Alzheimer's disease. Gerontology 1998; 44: 267-271.
22. Kang JH, Weuve J, Grodstein F. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology 2004; 63: 101-107.
23. Brinton RD, Chen S, Montoya M, Hsieh D, Minaya J. The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. Maturitas 2000; 34 (Suppl 2): S35-S52.
24. Zhao L, Brinton RD. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci 2006; 7: 24.
25. Walf AA, Frye CA. Conjugated equine estrogen enhances rats' cognitive, anxiety, and social behavior. Neuroreport 2008; 19: 789-792.
26. Acosta JI, Mayer L, Talboom JS etal. Premarin improves memory, prevents scopolamine-induced amnesia and increases number of basal forebrain choline acetyltransferase positive cells in middle-aged surgically menopausal rats. Horm Behav 2009; 55: 454-464.
27. Gleason CE, Schmitz TW, Hess T etal. Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation. Neurology 2006; 67: 2039-2041.
28. Sano M, Jacobs D, Andrews H etal. A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics. Clin Trials 2008; 5: 523-533.
29. Spencer JL, Waters EM, Romeo RD, Wood GE, Milner TA, McEwen BS. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol 2008; 29: 219-237.
30. Frick KM. Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here? Horm Behav 2009; 55: 2-23.
31. Calkins MJ, Reddy PH. Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: implications for impaired mitochondrial biogenesis and synaptic damage. Biochim Biophys Acta 2011; 1812: 1182-1189.
32. Calkins MJ, Reddy PH. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochim Biophys Acta 2011; 1812: 507-513.
33. Brissova M, Shostak A, Shiota M etal. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 2006; 55: 2974-2985.
34. Lammert E, Gu G, McLaughlin M etal. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003; 13: 1070-1074.
35. Lane RF, Raines SM, Steele JW etal. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. J Neurosci 2010; 30: 13110-13115.